Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-30
2011-08-30
Seaman, D M (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S302700
Reexamination Certificate
active
08008334
ABSTRACT:
The patent application relates to new heterocyclic compounds of the general formula (I) in which R, R1, R2, R3, R4and n have the definitions elucidated in more detail in the description, to a process for preparing them and to the use of these compounds as medicaments, particularly as aldosterone synthase inhibitors.
REFERENCES:
patent: 4889861 (1989-12-01), Browne
patent: 5026712 (1991-06-01), Davey
patent: 5057521 (1991-10-01), Häusler et al.
patent: 7612088 (2009-11-01), Herold et al.
patent: 7795253 (2010-09-01), Herold et al.
patent: 7799780 (2010-09-01), Herold et al.
patent: 2004/0033935 (2004-02-01), Tasaka et al.
patent: 2005/0043544 (2005-02-01), Nuwa et al.
patent: 2006/0177506 (2006-08-01), Yanai et al.
patent: 2007/0208035 (2007-09-01), Herold et al.
patent: 2007/0225232 (2007-09-01), Herold et al.
patent: 2008/0076784 (2008-03-01), Herold et al.
patent: 2008/0076794 (2008-03-01), Herold et al.
patent: 2008/0318978 (2008-12-01), Herold et al.
patent: 2009/0012068 (2009-01-01), Herold et al.
patent: 2009/0048241 (2009-02-01), Herold et al.
patent: 2009/0053308 (2009-02-01), Ishida et al.
patent: 2009/0111840 (2009-04-01), Herold et al.
patent: 2009/0192144 (2009-07-01), Herold et al.
patent: 2009/0192145 (2009-07-01), Herold et al.
patent: 2009/0192149 (2009-07-01), Herold et al.
patent: 2010/0010015 (2010-01-01), Herold et al.
patent: 2010/0029694 (2010-02-01), Herold et al.
patent: 2010/0168145 (2010-07-01), Herold et al.
patent: 2010/0305110 (2010-12-01), Herold et al.
patent: 2011/0028512 (2011-02-01), Herold et al.
patent: 2011/0092492 (2011-04-01), Herold et al.
patent: 1 471 056 (2004-10-01), None
patent: 1 607 092 (2005-12-01), None
patent: 63-145286 (1988-06-01), None
patent: 97/00257 (1997-01-01), None
patent: 9700257 (1997-01-01), None
patent: 02/40484 (2002-05-01), None
patent: 2004/082679 (2004-09-01), None
Stewart et al., “Cortisol Response to Dextroamphetamine Stimulation in Depressed Outpatients”, Psychiatry research, (1984), vol. 12, No. 3, pp. 195-206.
International Search Report issued Jun. 1, 2007 in the International (PCT) Application PCT/EP2006/069462 of which the present application is the U.S. National Stage.
PCT Written Opinion in the International (PCT) Application PCT/EP2006/069462 of which the present application is the U.S. National Stage.
Randall Lis et al., “Synthesis and Antiarrhythmic Activity of Novel 3-Alkyl-1-[ω[4-[(alkylsulfonyl)amino]phenyl]-ω-hydroxyalkyl]-1H-imidazolium Salts and Related Compounds”, Journal of Medicinal Chemistry, American Chemical Society, vol. 30, No. 12, pp. 2303-2309, XP000575891, ISSN: 0022-2623, Dec. 1, 1987.
Herold Peter
Mah Robert
Marti Christiane
Quirmbach Michael
Stojanovic Aleksandar
Novartis AG
Rahmani Niloofar
Seaman D M
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Bis-heterocyclic imidazolyl compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis-heterocyclic imidazolyl compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis-heterocyclic imidazolyl compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2697805